Patents by Inventor Karine Clément

Karine Clément has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200100534
    Abstract: Method of reducing weight regain in mammals after a hypocaloric weight-loss diet. A quinoa extract without saponins are used.
    Type: Application
    Filed: August 26, 2019
    Publication date: April 2, 2020
    Inventors: RENÉ LAFONT, KARINE CLEMENT, SALWA RIZKALLA, STANISLAS VEILLET, ANNE-SOPHIE FOUCAULT, WALY DIOH
  • Publication number: 20170071955
    Abstract: Phytoecdysones to avoid weight gain in obese mammals previously having undergone a hypocaloric weight-loss diet. The phytoecdysones are added to a food composition. The phytoecdysones can be from plants, such as quinoa.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 16, 2017
    Inventors: RENÉ LAFONT, KARINE CLEMENT, SALWA RIZKALLA, STANISLAS VEILLET, ANNE-SOPHIE FOUCAULT, WALY DIOH
  • Publication number: 20150275275
    Abstract: The present invention relates to a method for determining whether an overweight subject has a reduced gut bacterial diversity. The said method comprises detecting the presence or absence in a gut DNA sample of at least one gene of at least one bacterial species of Table 1 or Table 2, respectively.
    Type: Application
    Filed: October 17, 2013
    Publication date: October 1, 2015
    Inventors: Stanislav Ehrlich, Joel Dore, Emmanuelle Le Chatelier, Karine Clement, Jean-Daniel Zucker
  • Publication number: 20140309203
    Abstract: Phytoecdysones to avoid weight gain in obese mammals previously having undergone a hypocaloric weight-loss diet. The phytoecdysones are added to a food composition. The phytoecdysones can be from plants, such as quinoa.
    Type: Application
    Filed: November 12, 2012
    Publication date: October 16, 2014
    Inventors: Rene Lafont, Karine Clement, Salwa Rizkalla, Stanislas Veillet, Anne-Sophie Foucault, Waly Dioh
  • Publication number: 20140199326
    Abstract: The present invention relates to methods (and pharmaceutical compositions) for treating and/or preventing for obesity associated disorders, particularly related to a deregulation of glucose homeostasis, by administrating Cathepsin S inhibitors. The invention also relates to methods for diagnosing insulin resistance and glucose tolerance by measuring Cathepsin S levels in a biological sample obtained from a subject.
    Type: Application
    Filed: February 12, 2014
    Publication date: July 17, 2014
    Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Karine Clement, Michele Guerre Millo, Nadia Naour
  • Patent number: 8748493
    Abstract: The present invention relates to methods (and pharmaceutical compositions) for treating and/or preventing for obesity associated disorders, particularly related to a deregulation of glucose homeostasis, by administrating Cathepsin S inhibitors. The invention also relates to methods for diagnosing insulin resistance and glucose tolerance by measuring Cathepsin S levels in a biological sample obtained from a subject.
    Type: Grant
    Filed: March 22, 2010
    Date of Patent: June 10, 2014
    Assignee: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventors: Karine Clement, Michele Guerre Millo, Nadia Naour
  • Publication number: 20140030744
    Abstract: The present invention relates to the field of diagnostic measures. Specifically, it contemplates a method for assessing whether gastric bypass therapy was successful in a subject, a method of predicting whether gastric bypass therapy will be beneficial for a subject in need thereof, and a method of diagnosing whether a supportive therapy accompanying gastric bypass has beneficial effects on a subject in need thereof. Further provided are diagnostic methods for diabetes and body lean mass. Furthermore, the invention relates to a method for identifying a treatment against diabetes and/or obesity.
    Type: Application
    Filed: September 30, 2013
    Publication date: January 30, 2014
    Applicants: INSERM Institute National de la Sante et de la Recherche Medicale, Metanomics GmbH
    Inventors: Jens Fuhrmann, Dietrich Rein, Beate Kamlage, Jan C. Wiemer, Michael Manfred Herold, Karine Clément, David M. Mutch
  • Publication number: 20130183706
    Abstract: The present invention relates to a method for culturing adipocytes, in which a homogeneous population of mature adipocytes isolated from adipose tissue is cultured on a three-dimensional culture substrate.
    Type: Application
    Filed: May 23, 2011
    Publication date: July 18, 2013
    Applicants: ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)
    Inventors: Danièle Lacasa, Vanessa Pellegrinelli, Mayoura Keophiphath, Karine Clement
  • Publication number: 20110301242
    Abstract: The present invention relates to methods (and pharmaceutical compositions) for treating and/or preventing for obesity associated disorders, particularly related to a deregulation of glucose homeostasis, by administrating Cathepsin S inhibitors. The invention also relates to methods for diagnosing insulin resistance and glucose tolerance by measuring Cathepsin S levels in a biological sample obtained from a subject.
    Type: Application
    Filed: March 22, 2010
    Publication date: December 8, 2011
    Inventors: Karine Clement, Michele Guerre Millo, Nadia Naour
  • Publication number: 20110113863
    Abstract: The present invention relates to the field of diagnostic measures. Specifically, it contemplates a method for assessing whether gastric bypass therapy was successful in a subject, a method of predicting whether gastric bypass therapy will be beneficial for a subject in need thereof, and a method of diagnosing whether a supportive therapy accompanying gastric bypass has beneficial effects on a subject in need thereof. Further provided are diagnostic methods for diabetes and body lean mass. Furthermore, the invention relates to a method for identifying a treatment against diabetes and/or obesity.
    Type: Application
    Filed: July 15, 2009
    Publication date: May 19, 2011
    Applicants: Metanomics Health GmbH, INSERM Institute National de la Sante' et de la Recherche Medicale
    Inventors: Jens Fuhrmann, Dietrich Rein, Beate Kamlage, Jan C. Wiemer, Michael Manfred Herold, Karine Clément, David M. Mutch
  • Publication number: 20070199082
    Abstract: The invention relates to new methods of diagnosis of obesity, in particular morbid obesity, based on the identification of polymorphism in an intron and/or the promoter region of the WAC gene, to method of screening potential obesity therapeutics, to pharmaceutical composition comprising said therapeutics, to transgenic non-human mammal.
    Type: Application
    Filed: September 8, 2004
    Publication date: August 23, 2007
    Inventors: Philippe Froguel, Christian Dina, Philippe Boutin, Karin Seron, Karine Clement